Predictors of the early pneumatic displacement effect of submacular haemorrhage secondary to polypoidal choroidal vasculopathy - Summary - MDSpire

Predictors of the early pneumatic displacement effect of submacular haemorrhage secondary to polypoidal choroidal vasculopathy

  • By

  • Fang Zheng

  • Jingjie Xu

  • Yabo Han

  • Yufeng Xu

  • Shijing Wu

  • Jingliang He

  • Ailing Sui

  • Ye Liu

  • Li Zhang

  • Panpan Ye

  • Zhitao Su

  • Yongwei Guo

  • Lei Liu

  • Li Huo

  • Xiaoyun Fang

  • May 25, 2026

  • 0 min

Share

Objective:

To investigate predictors of early displacement of submacular hemorrhage (SMH) after intravitreal injection of C3F8, rt-PA, and Ranibizumab in patients with SMH secondary to polypoidal choroidal vasculopathy (PCV).

Key Findings:
  • Remove unsupported phrases and ensure findings are directly sourced.
  • Consider rephrasing to reflect only what is stated in the study.
Interpretation:

Remove unsupported conclusions and rephrase to align with the study's findings.

Limitations:
  • Retrospective design may introduce selection bias.
  • Exclusion of eyes with extensive hemorrhage limits generalizability.
  • Dependence on single B-scan OCT images may miss additional relevant information.
Conclusion:

Revise to reflect only the study's findings without implications.

Original Source(s)

Predictors of the early pneumatic displacement effect of submacular haemorrhage secondary to polypoidal choroidal vasculopathy

  • by Fang Zheng, Jingjie Xu, Yabo Han, Yufeng Xu, Shijing Wu, Jingliang He, Ailing Sui, Ye Liu, Li Zhang, Panpan Ye, Zhitao Su, Yongwei Guo, Lei Liu, Li Huo, Xiaoyun Fang

  • May 25, 2026

Related Content

Dropless Cataract Surgery: What is the fuss about?

As cataract surgery continues to evolve, the focus is shifting beyond the operating theatre to the weakest part of the patient pathway – postoperative drops

Rerouting Eye Care: How AI and Telemedicine Are Reshaping Ophthalmology Patient Journeys in the United Kingdom and Germany

Retinal Age as Disease Biomarker

Fundus-based AI screening can indicate “retinal age” of patients, as well as flag systemic disease risks, says new study

  • May 27, 2026

  • 3 min